Presented By: Patricia Hunt, Director of Child & Family Resiliency Services, Magellan & Gary Henschen, M.D., Chief Medical Officer – Behavioral Health, Magellan
Consumers, parents, caregivers and clinicians have expressed concern regarding the use of psychotropic medications in children and adolescents. A number of scientific articles recently have outlined the increasing role that medications play in the treatment of children, particularly children in foster care and in Medicaid. Some parents note that these medications have made a positive difference in the treatment of their child. Others report unexpected side effects, and report that no psychosocial evaluation occurred before the medication was prescribed, often by a primary care physician. Magellan Health Services has created a number of interventions in its Children’s Champion Program to address this issue.
- A review of interventions and tools to educate on the risks and benefits of psychotropic medications and important questions to ask of the prescriber when medications are suggested for a child’s treatment plan
- A discussion of the legitimate role of medications in the treatment of children for behavioral issues
- A review of the results of Magellan’s project to reduce inappropriate prescribing and improve the rate of children referred to case management
Following the main presentation, OPEN MINDS facilitated a Question and Answer session with Dr. Henschen and Ms. Hunt.
Download The Executive Web Briefing Below:
Download The Corresponding White Paper Below:
Continuing Education Credits:
Continuing Education credits are being offered for this webinar. For more information on obtaining CE credits, please read this document provided by Magellan Health Services:
CE Credit Document (PDF)